411 related articles for article (PubMed ID: 17504835)
1. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
Yuan CS
Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
[TBL] [Abstract][Full Text] [Related]
2. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
Yuan CS
J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
4. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
5. Methylnaltrexone: treatment for opioid-induced constipation.
Licup N; Baumrucker SJ
Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
[TBL] [Abstract][Full Text] [Related]
6. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
Baker DE
Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment of opioid-induced constipation.
Wang CZ; Yuan CS
Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of two opioid antagonists in treating opioid-induced constipation.
Healy R
Br J Nurs; 2009 Sep 10-23; 18(16):998-1002. PubMed ID: 19773693
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
10. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
11. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
Holzer P
Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
Nalamachu SR; Pergolizzi J; Taylor R; Slatkin NE; Barrett AC; Yu J; Bortey E; Paterson C; Forbes WP
Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
Yuan CS; Israel RJ
Expert Opin Investig Drugs; 2006 May; 15(5):541-52. PubMed ID: 16634692
[TBL] [Abstract][Full Text] [Related]
14. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
Shaiova L; Rim F; Friedman D; Jahdi M
Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
Lee JM; Mooney J
Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
[TBL] [Abstract][Full Text] [Related]
17. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
[TBL] [Abstract][Full Text] [Related]
18. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
[TBL] [Abstract][Full Text] [Related]
19. Opioid antagonists in the treatment of opioid-induced constipation and pruritus.
Friedman JD; Dello Buono FA
Ann Pharmacother; 2001 Jan; 35(1):85-91. PubMed ID: 11197589
[TBL] [Abstract][Full Text] [Related]
20. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
